Insulin Resistance and β Cell Function in Patients with β-Thalassemia Major

References

• Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353(11):1135–1146
   PubMed Web of Science ®Google Scholar
• Thein SL. Pathophysiology of β thalassemia – A guide to molecular therapies. Hematol Am Soc Hematol Educ Program. 2005:31–37
   Google Scholar
• Tangvarasittichai S, Pimanprom A, Choowet A, Tangvarasittichai O. Association of iron overload and oxidative stress with insulin resistance in transfusion-dependent β-thalassemia major and β-thalassemia/Hb E patients. Clin Lab. 2013;59(7–8):861–868
   PubMed Web of Science ®Google Scholar
• Swaminathan S, Fonseca VA, Alam MG, Shah SV. The role of iron in diabetes and its complications. Diabetes Care. 2007;30(7):1926–1933
   PubMed Web of Science ®Google Scholar
• Kurtoglu AU, Kurtoglu E, Temizkan AK. Effect of iron overload on endocrinopathies in patients with β-thalassaemia major and intermedia. Endokrynol Pol. 2012;63(4):260–263
   PubMed Web of Science ®Google Scholar
• Christoforidis A, Perifanis V, Tsatra I, et al. Evolution of OGTT in patients with β-thalassaemia major in relation to chelation therapy. Diabetes Res Clin Pract. 2007;76(1):6–11
   PubMed Web of Science ®Google Scholar
• Saffari F, Mahyar A, Jalilolgadr S. Endocrine and metabolic disorders in β-thalassemia major patients. Caspian J Intern Med. 2012;3(3):466–472
   PubMedGoogle Scholar
• Delvecchio M, Cavallo L. Growth and endocrine function in thalassemia major in childhood and adolescence. J Endocrinol Invest. 2010;33(1):61–68
   PubMed Web of Science ®Google Scholar
• Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab. 2013;17(3):329–341
   PubMed Web of Science ®Google Scholar
• Pappas S, Donohue SM, Denver AE, et al. Glucose intolerance in thalassemia major is related to insulin resistance and hepatic dysfunction. Metabolism. 1996;45(5):652–657
   PubMed Web of Science ®Google Scholar
• Angelopoulos NG, Zervas A, Livadas S, et al. Reduced insulin secretion in normoglycaemic patients with β-thalassaemia major. Diabet Med. 2006;23(12):1327–1331
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Soliman A, Yassin M. Iron overload and glucose metabolism in subjects with β-thalassaemia major: An overview. Curr Diabetes Rev. 2013;9(4):332–341
   PubMedGoogle Scholar
• Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and β-cell secretion in thalassaemia major with secondary hemochromatosis: Assessment by oral glucose tolerance test. Eur J Pediatr. 2003;162(3):139–146
   PubMed Web of Science ®Google Scholar
• Suvarna J, Ingle H, Deshmukh CT. Insulin resistance and β cell function in chronically transfused patients of thalassemia major. Indian Paediatr. 2006;43(5):393–400
   PubMed Web of Science ®Google Scholar
• de Assis RA, Ribeiro AA, Kay FU, et al. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in β thalassemic patients. Eur J Radiol. 2012;81(7):1465–1470
   PubMed Web of Science ®Google Scholar
• Shams S, Haghi Ashtiani MT, Monajemzadeh M, et al. Evaluation of serum insulin, glucose, lipid profile, and liver function in β-thalassemia major patients and their correlation with iron overload. Lab Med. 2010;41(8):486–489
   Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–S69
   PubMed Web of Science ®Google Scholar
• Haffner SM, Gonzales C, Miettinen H, et al. A prospective analysis of the HOMA model. Diabetes Care. 1996;19(10):1138–1141
   PubMed Web of Science ®Google Scholar
• Khalifa AS, Salem M, Mounir E, et al. Abnormal glucose tolerance in Egyptian β-thalassemic patients: Possible association with genotyping. Pediatr Diabetes. 2004;5(3):126–132
   PubMed Web of Science ®Google Scholar
• Hafez M, Youssry I, El-Hamed FA, Ibrahim A. Abnormal glucose tolerance in β-thalassemia: Assessment of risk factors. Hemoglobin. 2009;33(2):101–108
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Snehalatha C, Kapur A, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44(9):1094–1101
   PubMed Web of Science ®Google Scholar
• Noetzli LJ, Mittelman SD, Watanabe RM, et al. Pancreatic iron and glucose dysregulation in thalassemia major. Am J Hematol. 2012;87(2):155–160
   PubMed Web of Science ®Google Scholar
• el-Hazmi MA, al-Swailem A, al-Fawaz I, et al. Diabetes mellitus in children suffering from β-thalassemia. J Trop Pediatr. 1994;40(5):261–267
   PubMed Web of Science ®Google Scholar
• Chatterjee R, Bajoria R. New concept in natural history and management of diabetes mellitus in thalassemia major. Hemoglobin. 2009;33(Suppl 1):S127–S130
   Google Scholar
• Ragab LA, Hamdy MM, Shaheen IA, Yassin RN. Blood transfusion among thalassemia patients: A single Egyptian center experience. Asian J Transfus Sci. 2013;7(1):33–36
   PubMedGoogle Scholar
• Li MJ, Peng SS, Lu MY, et al. Diabetes mellitus in patients with thalassemia major. Pediatr Blood Cancer. 2014;61(1):20–24
   PubMed Web of Science ®Google Scholar
• Arrigo T, Crisafulli G, Meo A, et al. Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major. J Pediatr Endocrinol Metab. 1998;11(Suppl 3):863–866
   PubMedGoogle Scholar
• McClain DA, Abraham D, Rogers J, et al. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia. 2006;49(7):1661–1669
   PubMed Web of Science ®Google Scholar
• Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: Incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev. 2008;1(1):158–169
   Google Scholar
• Shah N, Mishra A, Chauhan D, Vora C. Study on effectiveness of transfusion program in thalassemia major patients receiving multiple blood transfusions at a transfusion centre in Western India. Asian J Transfus Sci. 2010;4(2):94–98
   PubMedGoogle Scholar
• Chen M, Feng T, Yang B, Tian H. Effect of iron overload on function of pancreatic β cells in rats. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2009;26(5):1088–1093
   PubMedGoogle Scholar
• Breuer W, Hershko C, Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci. 2000;23(3):185–192
   PubMedGoogle Scholar
• Taher A, Musallam KM, El Rassi F, et al. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia. Br J Haematol. 2009;146(5):569–572
   PubMed Web of Science ®Google Scholar